Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
502
-
Total 13F shares, excl. options
-
35.4M
-
Shares change
-
+383K
-
Total reported value, excl. options
-
$16B
-
Value change
-
+$196M
-
Put/Call ratio
-
2.26
-
Number of buys
-
232
-
Number of sells
-
-208
-
Price
-
$450.26
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q2 2021
560 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q2 2021.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 502 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.4M shares
of 152M outstanding shares and own 23.27% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.23M shares), VANGUARD GROUP INC (3.73M shares), BAMCO INC /NY/ (1.5M shares), STATE STREET CORP (1.22M shares), Ownership Capital B.V. (1.09M shares), BROWN CAPITAL MANAGEMENT LLC (1.08M shares), FRED ALGER MANAGEMENT, LLC (956K shares), Jackson Square Partners, LLC (808K shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (808K shares), and DF DENT & CO INC (766K shares).
This table shows the top 502 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.